POSSIS MEDICAL INC

Possis Medical Inc. supports cardiovascular care teams by supplying interventional devices and support services aligned with the SIC 3841 surgical instruments classification, focusing on the development of mechanically precise balloon catheters, angioplasty accessories, and the accompanying training programs that empower hospitals, cath labs, and physician specialists to deliver minimally invasive treatment. The company’s commercial strategy centers on clinicians and healthcare systems that prize reliable delivery tools for revascularization procedures, while its service model deepens relationships through installation, calibration, and on-site technical expertise. Operating without a ticker, Possis Medical nevertheless maintains compliance with federal oversight, so investors should weigh the customary device-market risks—regulatory approvals, reimbursement shifts, and supply-chain variations—alongside the uncertainty that comes with a most recent filing status that remains unspecified today; prospective partners must watch developments in FDA device listings and SEC disclosures. Readers tracking medical-device portfolios can view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025